Baidu
map

感染

订阅

MedSci主页 / 所有栏目 / 感染

JASN：口服抗生素与肾结石

2018-05-11 xing.T MedSci原创

口服抗生素肾结石
关注

由此可见，口服抗生素与肾结石发生率增加有关，近期接触和接触年龄较小与肾结石的可能性最大。这些结果对疾病发病机理以及肾结石发病率上升有影响，特别是在儿童中。

虽然肠道和尿微生物紊乱与肾结石有关，但抗生素是否是这种疾病的危险因素仍然未知的，近日，肾脏病领域权威杂志Journal of the American Society of Nephrology上针对这一问题发表一篇研究文章。

研究人员在基于人群的病例对照研究中明确了12类口服抗生素与肾结石之间的关联，该研究嵌套在英国1994至2015年期间超过1300万儿童和成人提供电子健康记录数据的641项常规实践。研究人员使用发病率密度抽样将25981例肾结石患者匹配年龄、性别和诊断日期一致的259797例对照者。条件logistic回归模型针对医疗保健、合并症、尿路感染以及使用噻嗪类和袢利尿剂、质子泵抑制剂和他汀类进行调整。

在诊断日期前3-12个月接触任何五种不同类别的抗生素与肾结石有关。调整后的比值比（95％可信区间）为2.33（2.19-2.48），头孢类抗生素为1.88（1.75-2.01）、氟喹诺酮类为1.67（1.54-1.81）、呋喃妥因/乌洛托品为1.70（1.55-1.88）、 广谱青霉素为1.27（1.18-1.36）。在探索性分析中，在较年轻的参与者中抗生素暴露后（P<0.001）和诊断日期前3-6个月（P<0.001），它们之间的相关性程度最大，除广谱青霉素之外，所有抗生素从暴露至3-5年后仍保持统计学显著性。

由此可见，口服抗生素与肾结石发生率增加有关，近期接触和接触年龄较小与肾结石的可能性最大。这些结果对疾病发病机理以及肾结石发病率上升有影响，特别是在儿童中。

原始出处：

Gregory E. Tasian,et al. Oral Antibiotic Exposure and Kidney Stone Disease.JASN,2018,http://jasn.asnjournals.org/content/early/2018/05/09/ASN.2017111213.abstract

本文系梅斯医学（MedSci）原创编译整理，转载需授权！


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1941352, encodeId=659c1941352f1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 22 02:11:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314859, encodeId=276a314859ec, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon May 14 00:16:53 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314773, encodeId=7ef3314e7395, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun May 13 16:50:39 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417315, encodeId=8857141e315d6, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun May 13 08:11:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314196, encodeId=f8f031419671, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 11 19:56:29 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2019-04-22 zhaojie88

    #ASN#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1941352, encodeId=659c1941352f1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 22 02:11:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314859, encodeId=276a314859ec, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon May 14 00:16:53 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314773, encodeId=7ef3314e7395, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun May 13 16:50:39 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417315, encodeId=8857141e315d6, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun May 13 08:11:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314196, encodeId=f8f031419671, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 11 19:56:29 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-14 秀红

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1941352, encodeId=659c1941352f1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 22 02:11:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314859, encodeId=276a314859ec, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon May 14 00:16:53 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314773, encodeId=7ef3314e7395, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun May 13 16:50:39 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417315, encodeId=8857141e315d6, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun May 13 08:11:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314196, encodeId=f8f031419671, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 11 19:56:29 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-13 wxl882001

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1941352, encodeId=659c1941352f1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 22 02:11:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314859, encodeId=276a314859ec, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon May 14 00:16:53 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314773, encodeId=7ef3314e7395, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun May 13 16:50:39 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417315, encodeId=8857141e315d6, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun May 13 08:11:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314196, encodeId=f8f031419671, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 11 19:56:29 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-13 dinorsor525

    #口服抗生素#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1941352, encodeId=659c1941352f1, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 22 02:11:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314859, encodeId=276a314859ec, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Mon May 14 00:16:53 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314773, encodeId=7ef3314e7395, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun May 13 16:50:39 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417315, encodeId=8857141e315d6, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun May 13 08:11:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314196, encodeId=f8f031419671, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri May 11 19:56:29 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-11 131****1460

    学习了受益匪浅

    0

相关资讯

Ann Rheum Dis：多学科讨论：口服避孕药和母乳喂养是否降低类风湿性关节炎风险？

类风湿性关节炎（RA）是最常见的自身免疫性疾病之一，病因学的遗传和环境因素的相互作用复杂。2017年11月，发表在《Ann Rheum Dis》的瑞典EIRA研究结果，考察了口服避孕药（OC）、母乳喂养（BF）与RA风险之间的相关性。请看本期多学科讨论组临床药师各抒己见为您梳理本文看点——

Aliment Pharm Therap：肝硬化门静脉高压患者 口服牛磺酸可改善疗效

2018年1月，发表于《Aliment Pharmacol Ther》上的一项随机临床试验，考察了口服牛磺酸（6g/d）vs安慰剂对肝硬化患者门静脉压力的影响。

Cardiovasc Diabetol：二线口服抗糖尿病药物大比拼：哪个能更好降低心血管风险？

二甲双胍用于治疗2型糖尿病的一线地位坚如磐石，被各国指南一致推荐为T2DM患者的标准一线药物，但始终没有确定哪种降糖药可力排众议稳坐二线治疗的第一把交椅。

Am J Kidney Dis：合并CKD-5D的房颤患者：口服抗凝药预防卒中效果如何？

2017年12月，发表在《Am J Kidney Dis》上的一项综述，对口服抗凝药用于合并5D期慢性肾病（CKD-5D）的房颤（AF）患者卒中预防的风险和获益的迫切性进行了阐述。

Clin Infect Dis：口服抗菌药厂商竞争的减少会使药物价格增加吗？

2017年发表在《Clin Infect Dis》上的一项研究，对美国口服抗菌药药物市场中价格趋势和仿制药竞争进行了考察。

Eur J Clin Pharmacol：快来看呀！房颤住院患者更具代表性的直接口服抗凝药试验

2017年发表在《Eur J Clin Pharmacol》的一项由澳大利亚科学家进行的横断面研究，考察了房颤（AF）住院患者中直接口服抗凝药（DOACs）临床试验的代表性。

Baidu
map
Baidu
map
Baidu
map